3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
15
Phase 3
4
Phase NA
2
Phase 1/2
2
Phase 4
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasm, Residual
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphohistiocytosis, Hemophagocytic
1
Hematologic Neoplasms
1
Interventions
Gemcitabine
2
Etoposide
2
Cisplatin
2
ruxolitinib
1
pegaspargase
1
Radiotherapy
1
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
1
Lenalidomide
1
Drug Therapy
1
Dexamethasone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Lymphoma, Extranodal NK-T-Cell
×
pegaspargase
×
Clear all
NCT04999878
2021-08-11
RUE-DDGP
Zhengzhou University
Phase 4
Unknown
30 enrolled